Pfizer's Jeffrey Kindler - CEO Pay
Jeffrey Kindler - Pfizer
Total Compensation: $12.6M
2007 Revenue: $48.6B
2006 Revenue: $48.3B
Change: .6%
Details: 2007 was not Pfizer's best year, seeing that the company started things off with one of the biggest drug development flops in recent history. CEO Jeffrey Kindler's pay is low when compared to rivals, but it was still up significantly from $9.8 million in 2006. Kindler pulled in $1.35 million in base pay, $3.1 million in cash bonuses (down slightly from 2006), $7.5 million in stock and options. His other compensation included $175,000 for aircraft use and over $42,000 for his use of a car.
Pfizer News:
Woe is Pfizer, analysts say
Investors, analysts not impressed with Pfizer
Is Pfizer's CEO as bold as promised?
Pfizer chiefs sees pay decline
Pfizer's Kindler leaves analysts feeling flat
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FiercePharma email newsletter for FREE!
Be the first to comment